Bausch Health · conference-presentation
Bausch Health Companies | Results Presentation Deck | 79 slides
79 pages · 4 arc beats · 2 loops
Bausch Health Companies | Results Presentation Deck | 79 slides
Bausch Health · 2021-05 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707579
Deck intelligence map
4 coverage by narrative range · generated from this deck JSON
Narrative range 79 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 4 slides 100% 4/4 slides 100% 4/4 slides · 12 hits — 0/4 slides
25% 1/4 slides 25% 1/4 slides 100% 4/4 slides — 0/4 slides
Need 6 slides 100% 6/6 slides 100% 6/6 slides · 29 hits — 0/6 slides
16.7% 1/6 slides · 2 hits — 0/6 slides
100% 6/6 slides 100% 6/6 slides Satisfaction 10 slides 100% 10/10 slides 100% 10/10 slides · 52 hits — 0/10 slides
40% 4/10 slides · 5 hits 10% 1/10 slides 100% 10/10 slides 100% 10/10 slides Action 59 slides 100% 59/59 slides 100% 59/59 slides · 244 hits — 0/59 slides
55.9% 33/59 slides · 34 hits 8.5% 5/59 slides 100% 59/59 slides 15.3% 9/59 slides Slide inventory
79 every slide · same image gating as the playbook
07
Includes a donut chart showing revenue breakdown by segment.summarize
08
Includes detailed footnotes regarding non-GAAP metrics and organizational restructuring.analyze_data
09
Includes GAAP and non-GAAP metrics with reported, constant currency, and organic change columns.analyze_data
10
Includes detailed footnotes explaining adjustments and specific financial events.analyze_data
11
Includes specific footnotes regarding debt settlement and restricted cash.analyze_data
12
The table uses a blue box to visually emphasize the 2021-2023 period with zero debt obligations.analyze_data
14
The slide includes detailed footnotes regarding non-GAAP adjustments and guidance methodology.analyze_data
15
The slide uses two separate waterfall-style bridges to explain changes in financial guidance.show_valuation_bridge
16
The slide uses a pie chart to show revenue distribution and bulleted lists to detail segment-specific performance metrics.analyze_data
17
The slide uses a mix of bar charts and line charts to illustrate recovery trajectories, with annotations highlighting specific performance periods.analyze_data
18
Includes a bar chart showing organic growth trends pre- and post-COVID-19.summarize
19
The slide uses trend lines to visually emphasize recovery trajectories for three pharmaceutical products.analyze_data
20
Includes a bar chart for organic growth, a donut chart for regional revenue, and callouts for top products by region overlaid on a world map.analyze_data
21
Includes non-GAAP metrics and specific product performance data.analyze_data
Open slide detailBeat · Action
23
Includes clinical trial data for NOV03 vs Saline.analyze_data
24
Includes footnotes referencing clinical trial data and market statistics.summarize
25
The slide uses a grid-based timeline to map four different drug development programs against calendar years from 2019 to 2027.plan_implementation
28
Uses a timeline-like flow diagram to show paths forward from 3Q21.plan_implementation
29
The slide uses a dual-track timeline approach, separating 'Internal Organizational Design / Structure' from 'Capital Structure' events.plan_implementation
30
Includes a footnote regarding the appointment status of the individuals.introduce_nominees
32
The slide uses a flow diagram to show how business lines were re-categorized under the new corporate structure.present_framework
Open slide detailBeat · Action
33
The slide uses a bridge-style table to show how reported figures were adjusted to restated figures.analyze_data
Open slide detailBeat · Action
34
The slide uses specific CAGR ranges to communicate growth expectations.summarize
Open slide detailBeat · Action
35
The slide uses a three-column layout to categorize updates by business unit.summarize
Open slide detailBeat · Action
36
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines for most units, with Salix being an exception.analyze_data
Open slide detailBeat · Action
37
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units due to patent expirations.analyze_data
Open slide detailBeat · Action
38
LOE stands for Loss of Exclusivity. The table shows revenue and profit figures in millions of dollars.analyze_data
Open slide detailBeat · Action
39
The table tracks inventory levels and period-over-period changes for specific business units.analyze_data
Open slide detailBeat · Action
40
The slide highlights a 2% organic revenue decline for the segment. Includes detailed footnotes regarding non-GAAP metrics and segment reporting.analyze_data
Open slide detailBeat · Action
41
Includes non-GAAP metrics like EBITA and organic growth.analyze_data
Open slide detailBeat · Action
42
Includes non-GAAP metrics and segment-specific performance data.analyze_data
Open slide detailBeat · Action
43
Includes a callout highlighting 35% organic revenue growth for Global Solta.analyze_data
Open slide detailBeat · Action
44
The slide highlights a 6% decline in WELLBUTRIN/APLENZIN revenue as a key driver.analyze_data
Open slide detailBeat · Action
45
The table compares Q1 2021 vs Q1 2020 performance with reported and constant currency variance metrics.analyze_data
Open slide detailBeat · Action
46
The table tracks quarterly revenue in millions of dollars for the top 10 products ranked by 1Q21 performance.analyze_data
Open slide detailBeat · Action
47
The table tracks revenue in millions of dollars for the top 10 products, ranked by 1Q21 performance.analyze_data
Open slide detailBeat · Action
48
The table lists products by rank and provides quarterly revenue figures in millions of dollars.analyze_data
Open slide detailBeat · Action
49
The table tracks revenue in millions of dollars for 10 products from 1Q20 to 1Q21.analyze_data
Open slide detailBeat · Action
50
The table lists products by rank and provides revenue figures in millions of dollars for each of the last five quarters.analyze_data
Open slide detailBeat · Action
51
The table lists products ranked by revenue in 1Q21, with historical data for the previous four quarters.analyze_data
Open slide detailBeat · Action
52
The table details specific line items like amortization, impairments, and restructuring costs, showing their impact on both total income and EPS.analyze_data
Open slide detailBeat · Action
53
Includes a callout box clarifying that corporate G&A and R&D are not allocated.analyze_data
Open slide detailBeat · Action
54
Includes footnotes regarding segment reporting and estimates.analyze_data
Open slide detailBeat · Action
55
The slide includes two distinct tables: one for Revenue and one for Adj. Segment Profit/EBITA. It also includes a disclaimer about G&A and R&D allocation.analyze_data
Open slide detailBeat · Action
56
The slide provides supplemental financial metrics including R&D, G&A, Depreciation, CapEx, and Stock-Based Compensation.analyze_data
Open slide detailBeat · Action
57
The table includes revenue, adjusted gross profit, adjusted gross margin, R&D, SG&A, and adjusted segment profit/EBITA.analyze_data
Open slide detailBeat · Action
58
The table includes a mix of quarterly and annual data columns.analyze_data
Open slide detailBeat · Action
59
The table includes a 'New Segment Structure' callout and detailed footnotes regarding non-GAAP adjustments and segment realignment.analyze_data
Open slide detailBeat · Action
60
The table includes a mix of quarterly and annual data columns.analyze_data
Open slide detailBeat · Action
61
The slide presents two separate tables for YTD 2021 and YTD 2020, detailing specific line-item adjustments.analyze_data
Open slide detailBeat · Action
62
Includes footnotes regarding asset impairment definitions and segment reporting structure.analyze_data
Open slide detailBeat · Action
63
The table reconciles GAAP to non-GAAP figures by adding back acquisition-related costs and adjustments.analyze_data
Open slide detailBeat · Action
64
The slide provides a detailed breakdown of non-GAAP financial adjustments.analyze_data
Open slide detailBeat · Action
65
This is a standard financial disclosure slide providing a bridge between GAAP and non-GAAP metrics.analyze_data
Open slide detailBeat · Action
66
The table is split into two main sections: the left side calculates organic revenue for 2020/2019 periods, and the right side calculates organic revenue growth analyze_data
Open slide detailBeat · Action
67
The table reconciles reported revenue to organic revenue by adjusting for exchange rates, divestitures, and discontinuations.analyze_data
Open slide detailBeat · Action
68
The table is split into two main sections: one adjusting for exchange rates and one adjusting for divestitures/discontinuations, leading to a final organic growanalyze_data
Open slide detailBeat · Action
69
The table adjusts reported revenue for exchange rates and divestitures to arrive at organic revenue.analyze_data
Open slide detailBeat · Action
70
The slide provides a bridge between GAAP and non-GAAP cash flow metrics by adding back specific legal and separation costs.analyze_data
Open slide detailBeat · Action
72
The right-hand sidebar acts as a navigation menu for the appendix section.appendix
Open slide detailBeat · Action
73
The slide includes a sidebar listing various non-GAAP financial measures.appendix
Open slide detailBeat · Action
74
The right-hand sidebar lists specific non-GAAP metrics, while the main body text explains the rationale for excluding specific items like share-based compensatiappendix
Open slide detailBeat · Action
75
The right-hand sidebar lists various non-GAAP financial measures covered in the appendix.appendix
Open slide detailBeat · Action
76
The slide serves as a glossary/disclosure for non-GAAP metrics used in the presentation.appendix
Open slide detailBeat · Action
77
The right-hand sidebar acts as a navigation menu for the appendix section.appendix
Open slide detailBeat · Action
78
The right sidebar acts as a navigation menu for the appendix section.appendix
Open slide detailBeat · Action
79
The right-hand sidebar acts as a navigation menu for the appendix section.appendix
Open slide detailBeat · Action